A207940 Share Price Performance
₩1,129,000.00
72000.00 (6.81%)
Price ₩1,129,000.00
Share Price₩1,129,000.00
Samsung Biologics Co.,Ltd.'s (KRX:207940) P/E Still Appears To Be Reasonable
Sep 07
Samsung Biologics Co.,Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
A207940 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Samsung Biologics Co.,Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- 18.07k
- 52.54%
- 25.56%
- 11.6%
About A207940
- Founded
- 2011
- Employees
- 5047
- CEO
- WebsiteView website
Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates through Contract Development and Manufacturing Organization (CDMO), and Biopharmaceutical Development and Commercialization segments. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and regulatory support services; and quality, biosafety and analytical testing services, as well as manufactures drug substance. In addition, it engages in the development and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.